American Psychiatric Association, editor. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. 2013. https://doi.org/10.1176/appi.books.9780890425596.

World Health Organization. International Classification of Diseases. Eleventh Revision (ICD-11). 2021. https://icd.who.int/browse11.

Hasin DS, Shmulewitz D, Stohl M, Greenstein E, Aharonovich E, Petronis KR, Von Korff M, Datta S, Sonty N, Ross S, Inturrisi C, Weinberger ML, Scodes J, Wall MM. Diagnosing prescription opioid use disorder in patients using prescribed opioids for chronic pain. Am J Psychiatry. 2022;179(10):715–25. https://doi.org/10.1176/appi.ajp.21070721.

Article  PubMed  Google Scholar 

Cosci F, Chouinard G. Acute and persistent withdrawal syndromes following discontinuation of psychotropic medications. Psychother Psychosom. 2020;89(5):283–306. https://doi.org/10.1159/000506868.

Article  PubMed  Google Scholar 

Kirisci L, Tarter RE, Reynolds M, Vanyukov MM. Item response theory analysis to assess dimensionality of substance use disorder abuse and dependence symptoms. Int J Pers Cent Med. 2016;6(4):260–73.

PubMed  PubMed Central  Google Scholar 

Lane SP, Sher KJ. Limits of current approaches to diagnosis severity based on criterion counts: an example with DSM-5 Alcohol Use Disorder. Clin Psychol Sci. 2015;3(6):819–35. https://doi.org/10.1177/2167702614553026.

Article  PubMed  Google Scholar 

Sinnott-Armstrong W, Summers JS. Defining addiction: a pragmatic perspective. In: Pickard H, Ahmed SH, editors. The Routledge Handbook of Philosophy and Science of Addiction. New York: Taylor and Francis; 2019. p. 123–31.

Google Scholar 

Watts AL, Boness CL, Loeffelman JE, Steinley D, Sher KJ. Does crude measurement contribute to observed unidimensionality of psychological constructs? A demonstration with DSM-5 alcohol use disorder. J Abnorm Psychol. 2021;130(5):512–24. https://doi.org/10.1037/abn0000678.

Article  PubMed  PubMed Central  Google Scholar 

Singh D, Narayanan S, Vicknasingam B. Traditional and non-traditional uses of Mitragynine (Kratom): A survey of the literature. Brain Res Bull. 2016;126(Pt 1):41–6. https://doi.org/10.1016/j.brainresbull.2016.05.004.

Article  CAS  PubMed  Google Scholar 

Zinberg NE. Drug, Set, and Setting: The Basis for Controlled Intoxicant Use. New Haven, CT: Yale University Press; 1984.

Google Scholar 

Saingam D, Assanangkornchai S, Geater AF, Balthip Q. Pattern and consequences of krathom (Mitragyna speciosa Korth.) use among male villagers in southern Thailand: a qualitative study. Int J Drug Policy. 2013;24(4):351–8. https://doi.org/10.1016/j.drugpo.2012.09.004.

Article  PubMed  Google Scholar 

Saingam D, Assanangkornchai S, Geater AF, Lerkiatbundit S. Validation of Krathom (Mitragyna speciosa Korth.) Dependence Scale (KDS): a dependence screen for internationally emerging psychoactive substance. Subst Abus. 2014;35(3):276–83. https://doi.org/10.1080/08897077.2014.924464.

Article  PubMed  Google Scholar 

Smith KE, Feldman JD, Dunn KE, McCurdy CR, Weiss ST, Grundmann O, Garcia-Romeu A, Nichels J, Epstein DH. Examining the paradoxical effects of kratom: a narrative inquiry. Front Pharmacol. 2023;14:1174139. https://doi.org/10.3389/fphar.2023.1174139.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rogers JM, Colvin K, Epstein DH, Grundmann O, McCurdy CR, Smith KE. Growing pains with kratom: experiences discussed in subreddits contrast with satisfaction expressed in surveys. Front Phamacol. 2024. https://doi.org/10.3389/fphar.2024.1412397.

Article  Google Scholar 

Smith KE, Feldman JD, Schriefer D, Weiss ST, Grundmann O, Dunn KE, Singh D, McCurdy CR, Butera G, Epstein DH. Diagnostic ambiguities and underuse of clinical assessment tools: A systematic review of case reports on kratom addiction and physical dependence. Curr Addict Rep. 2023;10(2):282–92.

Google Scholar 

Henningfield JE, Chawarski MC, Garcia-Romeu A, Grundmann O, Harun N, Hassan Z, McCurdy CR, McMahon LR, Sharma A, Shoaib M, Singh D, Smith KE, Swogger MT, Vicknasingam B, Walsh Z, Wang DW, Huestis MA. Kratom withdrawal: Discussions and conclusions of a scientific expert forum. Drug Alcohol Depend Rep. 2023;7. https://doi.org/10.1016/j.dadr.2023.100142.

Article  PubMed  PubMed Central  Google Scholar 

Rogers JM, Weiss ST, Epstein DH, Grundmann O, Hill K, Smith KE. Kratom addiction per DSM-5 SUD criteria, and kratom physical dependence: Insights from dosing amount versus frequency. Drug Alcohol Depend. 2024. https://doi.org/10.1016/j.drugalcdep.2024.111329.

Article  PubMed  Google Scholar 

Grundmann O, Hill K, Al Barzanji E, Hazrat NG, Kaur G, Negeve RE, Shade S, Weber S, Veltri CA. Correlations of kratom (Mitragyna speciosa Korth.) tea bag preparations and reported pharmacological effects. J Ethnopharmacol. 2023;317:116779. https://doi.org/10.1016/j.jep.2023.116779.

Article  CAS  PubMed  Google Scholar 

Garcia-Romeu A, Cox DJ, Smith KE, Dunn KE, Griffiths RR. Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic. Drug Alcohol Depend. 2020;208. https://doi.org/10.1016/j.drugalcdep.2020.107849.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hill K, Grundmann O, Smith KE, Stanciu CN. Prevalence of kratom use disorder among kratom consumers. J Addict Med. 2024. https://doi.org/10.1097/ADM.0000000000001290.

Article  PubMed  Google Scholar 

Smith KE, Dunn KE, Grundmann O, Garcia-Romeu A, Rogers JM, Swogger MT, Epstein DH. Social, psychological, and substance use characteristics of U.S. adults who use kratom: Initial findings from an online, crowdsourced study. Exp Clin Psychopharmacol. 2022;30(6):983–96. https://doi.org/10.1037/pha0000518.

Article  PubMed  Google Scholar 

Rogers JM, Smith KE, Schriefer D, Epstein DH. For better or worse: self-reported changes in kratom and other substance use as a result of the Covid-19 pandemic. Subst Abuse. 2022;16:11782218221123976. https://doi.org/10.1177/11782218221123977.

Article  PubMed  PubMed Central  Google Scholar 

Smith KE, Rogers JM, Dunn KE, Grundmann O, McCurdy CR, Schriefer D, Epstein DH. Searching for a signal: self-reported kratom dose-effect relationships among a sample of US adults with regular kratom use histories. Front Pharmacol. 2022;13. https://doi.org/10.3389/fphar.2022.765917.

Article  PubMed  PubMed Central  Google Scholar 

Smith KE, Dunn KE, Rogers JM, Garcia-Romeu A, Strickland JC, Epstein DH. Assessment of kratom use disorder and withdrawal among an online convenience sample of US adults. J Addict Med. 2022. https://doi.org/10.1097/ADM.0000000000000986.

Article  PubMed  PubMed Central  Google Scholar 

Smith KE, Panlilio LV, Feldman JD, Grundmann O, Dunn KE, McCurdy CR, Garcia-Romeu A, Epstein DH. Kratom use, effects and motivations: a nationwide field study using ecological momentary assessment. JAMA Network Open. 2024. https://doi.org/10.1001/jamanetworkopen.2023.53401.

Article  PubMed  PubMed Central  Google Scholar 

Smith KE, Rogers JM, Sharma A, McCurdy CR, Weiss ST, Dunn KE, Feldman JD, Kuntz MA, Mukhopadhyay S, Raju KSR, Taylor RC, Epstein DH. Responses to a “typical” morning dose of kratom in people who use kratom regularly: a direct-observation study. J Addict Med. 2024. https://doi.org/10.1097/ADM.0000000000001259.

Article  PubMed  Google Scholar 

Zamarripa CA, Spindle TR, Panlilio LV, Strickland JC, Feldman JD, Novak MD, Epstein DH, Dunn KE, McCurdy CR, Sharma A, Kuntz MA, Mukhopadhyay S, Raju KSR, Rogers JM, Smith KE. Effects of kratom on driving: Results from a cross-sectional survey, ecological momentary assessment, and pilot simulated driving study. Traffic Inj Prev. 2024;1–10. https://doi.org/10.1080/15389588.2024.2327827.

Griffiths RR, Chausmer AL. Caffeine as a model drug of dependence: recent developments in understanding caffeine withdrawal, the caffeine dependence syndrome, and caffeine negative reinforcement. Nihon Shinkei Seishin Yakurigaku Zasshi. 2000;20(5):223–31.

CAS  PubMed  Google Scholar 

Addicott MA. Caffeine use disorder: a review of the evidence and future implications. Curr Addict Rep. 2014;1(3):186–92. https://doi.org/10.1007/s40429-014-0024-9.

Article  PubMed  PubMed Central  Google Scholar 

Boyer EW, Babu KM, Adkins JE, McCurdy CR, Halpern JH. Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth). Addiction. 2008;103(6):1048–50. https://doi.org/10.1111/j.1360-0443.2008.02209.x.

Article  PubMed  PubMed Central  Google Scholar 

Grundmann O, Garcia-Romeu A, McCurdy CR, Sharma A, Smith KE, Swogger MT, Weiss ST. Not all kratom is equal: The important distinction between native leaf and extract products. Addiction. 2024;119(1):202–3. https://doi.org/10.1111/add.16366.

Article  PubMed  Google Scholar 

Weiss ST, Brent JA. A cautionary tale of herbal supplements: What we have learned from kratom. Curr Addict Rep. 2023;10(1):1–8. https://doi.org/10.1007/s40429-023-00465-8.

Article